STAAR Surgical Profit Margin 2010-2024 | STAA
Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of December 31, 2024 is -6.44%.
| STAAR Surgical Annual Profit Margins |
|---|
| STAAR Surgical Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.870B | $0.314B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $84.343B | 23.08 |
| Becton Dickinson (BDX) | United States | $65.771B | 16.47 |
| Cardinal Health (CAH) | United States | $33.281B | 17.82 |
| Labcorp (LH) | United States | $19.480B | 15.97 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.198B | 0.00 |
| Cooper (COO) | United States | $16.868B | 22.37 |
| West Pharmaceutical Services (WST) | United States | $16.185B | 33.17 |
| Align Technology (ALGN) | United States | $11.630B | 22.53 |
| Henry Schein (HSIC) | United States | $8.505B | 14.45 |
| Merit Medical Systems (MMSI) | United States | $6.219B | 30.38 |
| DENTSPLY SIRONA (XRAY) | United States | $2.973B | 8.95 |
| Patterson (PDCO) | United States | $2.764B | 15.94 |
| CONMED (CNMD) | United States | $1.867B | 14.52 |
| Lifevantage (LFVN) | United States | $0.183B | 20.25 |
| Pro-Dex (PDEX) | United States | $0.162B | 24.67 |